Registration number: 08103999

Q Rx Limited

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

Q Rx Limited

Company Information

Director

Mr S Y Wagle

Registered office

15 Alverton Street Penzance Cornwall TR18 2QP

Accountants

D.J. Reynolds & Co. 15 Alverton Street Penzance Cornwall TR18 2QP

Q Rx Limited

(Registration number: 08103999)
Balance Sheet as at 30 June 2025

	2025 £	2024 £
Fixed assets	1,129	609
Current assets	27,472	15,465
Creditors: Amounts falling due within one year	(10,762)	(9,310)
Net current assets	16,710	6,155
Total assets less current liabilities	17,839	6,764
Creditors: Amounts falling due after more than one year	(4,294)	(5,614)
Provisions for liabilities	(215)	-
Accruals and deferred income	(800)	(600)
	12,530	550
Capital and reserves	12,530	550

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
15 Alverton Street
Penzance
Cornwall
TR18 2QP

These financial statements were authorised for issue by the director on 19 April 2026.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency in these financial statements is GB pounds sterling £.

2	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Q Rx Limited

(Registration number: 08103999)
Balance Sheet as at 30 June 2025

3	Related party transactions

Transactions with the director

2025	At 1 July 2024 £	Advances to director £	Repayments by director £	At 30 June 2025 £
Mr S Y Wagle
Interest-free and repayable on demand	10,584	33,225	(19,126)	24,683

2024	At 1 July 2023 £	Advances to director £	Repayments by director £	At 30 June 2024 £
Mr S Y Wagle
Interest-free and repayable on demand	8,103	7,476	(4,995)	10,584

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the director on 19 April 2026
 

......................................... Mr S Y Wagle Director